SANA
Sana Biotechnology Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.36
+0.27 ▲ +8.74%
🌙 3월 13일 7:54 PM ET (한국 3/14 08:54)
$3.28
-0.08 ▼ -2.41%
| Index | RUT | P/E | - | EPS (ttm) | -0.98 | Insider Own | 37.73% | Shs Outstand | 0.27B | Perf Week | 6.67% |
| Market Cap | 0.90B | Forward P/E | - | EPS next Y | -2.76% | Insider Trans | - | Shs Float | 0.17B | Perf Month | -13.4% |
| Enterprise Value | 0.83B | PEG | - | EPS next Q | -0.16 | Inst Own | 48.76% | Short Float | 21.56% | Perf Quarter | -31.98% |
| Income | -0.24B | P/S | - | EPS this Y | 34.49% | Inst Trans | -2.2% | Short Ratio | 13.18 | Perf Half Y | -1.18% |
| Sales | 0.00B | P/B | 5.57 | EPS next 5Y | 10.61% | ROA | -52.64% | Short Interest | 35.83M | Perf YTD | -17.44% |
| Book/sh | 0.6 | P/C | 6.29 | EPS past 3/5Y | 12.33% 8.72% | ROE | -118.7% | 52W High | -48.7% ($6.55) | Perf Year | 26.55% |
| Cash/sh | 0.53 | P/FCF | - | Sales past 3/5Y | - | ROIC | -108.61% | 52W Low | 166.67% ($1.26) | Perf 3Y | -3.72% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 16.65% | Gross Margin | - | Volatility(W/M) | 6.81% 6.92% | Perf 5Y | -89.12% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.28 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.89 | EPS Q/Q | -2.65% | Profit Margin | - | RSI (14) | 39.38 | Recom | 1.22 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.89 | Sales Q/Q | - | SMA20 | -10.89% ($3.77) | Beta | 2.03 | Target Price | $8.43 |
| Payout | - | Debt/Eq | 0.49 | Earnings | 3000000 | SMA50 | -19.21% ($4.16) | Rel Volume | 1.68 | Prev Close | $3.09 |
| Employees | 142 | LT Debt/Eq | 0.4 | EPS/Sales Surpr. | -47.78% - | SMA200 | -14.06% ($3.91) | Avg Volume(3M) | 2.72M | Price | $3.36 |
| IPO | 2021/2/4 | Option/Short | Yes/Yes | Trades | 12499 | Volume | 4,554,138 | Change | 8.74% |
뉴스 로딩 중...